Lanzamiento Enero 2027

Ensayo controlado aleatorizado1996Financiación no declarada

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease

Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M

The New England journal of medicine · 442 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1996-06-13 · N Engl J Med · vol. 334 · número 24 · págs. 1557–1560
Editorial
Massachusetts Medical Society
Citado
766 citas · más que el 100% de estudios similares · 21.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
33 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Inflammatory Bowel Disease · Fatty Acid Research and Health · Rheumatoid Arthritis Research and Therapies
Palabras clave
Crohn's disease, fish oil, omega-3 fatty acids, enteric-coated capsules, relapse prevention, remission maintenance, anti-inflammatory therapy, gastrointestinal adverse effects
MeSH
humans, crohn disease, recurrence, fatty acids, omega-3, fatty acids, unsaturated, fatty acids, omega-6, fish oils, anti-inflammatory agents, capsules, tablets, enteric-coated, treatment outcome, multivariate analysis, logistic models, double-blind method, adult, aged, middle aged, female, male, biomarkers

6 autores

  • Andrea Belluzzi🇮🇹University of Bologna
  • Corrado Brignola🇮🇹University of Bologna
  • Massimo Campieri🇮🇹University of Bologna
  • Angelo Pera🇮🇹Azienda Ospedaliero Universitaria San Giovanni Battista
  • Stefano Boschi🇮🇹University of Bologna
  • Mario Miglioli🇮🇹University of Bologna

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Patients with Crohn's disease may have periods of remission, interrupted by relapses. Because fish oil has antiinflammatory actions, it could reduce the frequency of relapses, but it is often poorly tolerated because of its unpleasant taste and gastrointestinal side effects.

Methods

We performed a one-year, double-blind, placebo-controlled study to investigate the effects of a new fish-oil preparation in the maintenance of remission in 78 patients with Crohn's disease who had a high risk of relapse. The patients received either nine fish-oil capsules containing a total of 2.7 g of n-3 fatty acids or nine placebo capsules daily. A special coating protected the capsules against gastric acidity for at least 30 minutes.

Results

Among the 39 patients in the fish-oil group, 11 (28 percent) had relapses, 4 dropped out because of diarrhea, and 1 withdrew for other reasons. In contrast, among the 39 patients in the placebo group, 27 (69 percent) had relapses, 1 dropped out because of diarrhea, and 1 withdrew for other reasons (difference in relapse rate, 41 percentage points; 95 percent confidence interval, 21 to 61; P < 0.001). After one year, 23 patients (59 percent) in the fish-oil group remained in remission, as compared with 10 (26 percent) in the placebo group (P = 0.003). Logistic-regression analysis indicated that only fish oil and not sex, age, previous surgery, duration of disease, or smoking status affected the likelihood of relapse (odds ratio for the placebo group as compared with the fish-oil group, 4.2; 95 percent confidence interval, 1.6 to 10.7).

Conclusions

In patients with Crohn's disease in remission, a novel enteric-coated fish-oil preparation is effective in reducing the rate of relapse.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.